What the Research Says BPC-157: Evidence Overview What the Research Supports (Animal Models) The majority of BPC-157 research has been conducted in rodent models and has demonstrated: Accelerated healing of tendon, ligament, and muscle injuries Gastroprotective effects against NSAID-induced ulcers and inflammatory bowel lesions Neuroprotection in models of traumatic brain injury and peripheral nerve damage Systemic anti-inflammatory activity Bone healing support and osteoblast activity enhancement The animal research for BPC-157 is genuinely compelling in breadth
The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression
That means that there is some very preliminary evidence that it can slow down skin cancer growth [9]
Thus, we speculated that the site-specific insertion of a tissue-specific enhancer might upregulate target gene expression physiologically and spatiotemporally, consequently preserving its original regulatory network and decreasing the abnormalities induced by the forced transgene expression
Swaner JC, Connor WE: Hypercholesterolemia of total starvation: Its mechanism via tissue mobilization of cholesterol
Membranes were probed with anti-GCLC sc-390811 (200 ng/ml), anti-ACTB sc-69879 (5 ng/ml), and anti-Vinculin sc-73614 (200 ng/ml), both from Santa Cruz Biotechonology (Santa Cruz, CA, USA) followed by goat anti-mouse IgG conjugated to IR-800Dye (926-32210